Maybe it's not the patent so much as it is the data protection that comes underneath it, because there are technologies that come out of biotech that aren't patentable or protected. It is the investment you make in terms of proving that the technology is of value and the data that's generated. How is that protected? Canada is a bit of a laggard in that space. There are always things we can do if we really want to lead and improve on that one.
The other piece I would raise on IP is the opportunity or challenge we have in dealing with IP tech transfer. We invest tremendously in universities in research and development. We have good IP that's being developed. How does that come out to be commercialized? Some universities do it better than others.